51 citations · 112 across the 9 of their papers we have counts for
7 papers · 1 filter
Evolution of funding for collaborative health research towards higher-level patient-oriented research. A comparison of the European Union Framework Programmes to the program funding by the United States National Institutes of Health
David Fajardo-Ortiz, Bart Thijs, Wolfgang Glanzel +1
Public research funding agencies increasingly seek to steer health research toward higher levels of translation and societal relevance. Yet it remains unclear to what extent such p…
Funding CRISPR: Understanding the role of government and philanthropic institutions in supporting academic research within the CRISPR innovation system
David Fajardo-Ortiz, Stefan Hornbostel, Maywa Montenegro-de-Wit +1
CRISPR/Cas has the potential to revolutionize medicine, agriculture, and biology. Understanding the trajectory of CRISPR research, how it is influenced and who pays for it, is an e…
Team assembly mechanisms and the knowledge produced in the Mexico's National Institute of Geriatrics: a network analysis and agent-based modelling approach
Carmen García-Peña, Luis Miguel Gutiérrez-Robledo, Augusto Cabrera-Becerril +1
Mexico's National Institute of Geriatrics (INGER) is the national research center of reference for matters related to human aging. INGER scientists perform basic, clinical and demo…
Emerging basic, clinical and translational research fronts in dental biomaterials R&D
David Fajardo-Ortiz, Pablo Jaramillo, Claudia Jaramillo +3
The current (2007-2007) structure and content of dental materials research has been investigated by identifying and describing the emergent research fronts which can be related to…
Hegemonic structure of basic, clinical and patented knowledge on Ebola research: a US army reductionist initiative
David Fajardo-Ortiz, Josw Ortega-Sanchez-de-Tagle, Victor-M Castano
Background: In this paper, we present an approach to understand how the basic, clinical and patent knowledge on Ebola is organized and intercommunicated and what leading factor cou…
Mapping knowledge translation and innovation processes in Cancer Drug Development: the case of liposomal doxorubicin
David Fajardo-Ortiz, Luis Duran, Laura Moreno +2
We explored how the knowledge translation and innovation processes are structured when they result in innovations, as in the case of liposomal doxorubicin research. In order to map…
Liposomes versus metallic nanostructures: differences in the process of knowledge translation in cancer
David Fajardo-Ortiz, Luis Duran, Laura Moreno +2
This research maps the knowledge translation process for two different types of nanotechnologies applied to cancer: liposomes and metallic nanostructures (MNs). We performed a stru…